| Literature DB >> 12545159 |
Seung-Hoon Lee1, Jung-Whan Kim, Han-Woong Lee, Yong-Suk Cho, Sun-Hee Oh, Yong-Jin Kim, Chul-Ho Jung, Wei Zhang, Je-Ho Lee.
Abstract
Constitutive activation of the telomerase is a key step in the development of human cancers. Interferon-gamma (IFN-gamma) signaling induces growth arrest in many tumors through multiple regulatory mechanisms. In this study, we show that IFN-gamma signaling represses telomerase activity and human telomerase reverse transcriptase (hTERT) transcription, and suggest that this signaling is mediated by IRF-1. Ectopic expression of IRF-1 attenuated hTERT promoter activity. Murine embryonic fibroblasts (MEFs) genetically deficient in IRF-1 (IRF-1(-/-)) showed an elevated level (>15 times) of hTERT promoter activity as compared to the hTERT promoter activity of wild-type MEFs. The telomerase activity and hTERT expression in IRF-1(-/-) MEFs were downregulated by IRF-1 transfection. Interestingly, less extent of telomerase repression was observed in HPV E6 and E7 negative, p53 mutant HT-3 cells than in HPV 18 E6 and E7 positive HeLa cells (intact p53). These findings provide evidence that IRF-1 is a potential mediator of IFN-gamma-induced attenuation of telomerase activity and hTERT expression.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12545159 DOI: 10.1038/sj.onc.1206133
Source DB: PubMed Journal: Oncogene ISSN: 0950-9232 Impact factor: 9.867